BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11407129)

  • 1. Olanzapine: another psychotropic?
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(2):129-32. PubMed ID: 11407129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focus on olanzapine.
    Green B
    Curr Med Res Opin; 1999; 15(2):79-85. PubMed ID: 10494490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The change from clozapine to olanzapine--same effect?].
    Pomp E
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):945-6. PubMed ID: 10795501
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN; Wasylink S; Epperson CN; McDougle CJ
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Olanzapine in the treatment of depressive disorders with psychotic symptoms].
    Adli M; Rossius W; Bauer M
    Nervenarzt; 1999 Jan; 70(1):68-71. PubMed ID: 10087520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D; de Suray JM; Vandenhende F; Onkelinx C; Gangji D
    AAPS PharmSci; 2002; 4(2):E11. PubMed ID: 12102620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
    Melkersson K; Hulting AL
    Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperglycemia and ketoacidosis associated with olanzapine].
    Von Hayek D; Hüttl V; Reiss J; Schweiger HD; Füessl HS
    Nervenarzt; 1999 Sep; 70(9):836-7. PubMed ID: 10522253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E; Braus DF; Cavus I; Thome J
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    Marazziti D; Pallanti S
    Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
    [No Abstract]   [Full Text] [Related]  

  • 15. The economic consequences of a drug-drug interaction.
    Shad MU; Marsh C; Preskorn SH
    J Clin Psychopharmacol; 2001 Feb; 21(1):119-20. PubMed ID: 11199940
    [No Abstract]   [Full Text] [Related]  

  • 16. Remission of tardive dyskinesia after changing from flupenthixol to olanzapine.
    Haberfellner EM
    Eur Psychiatry; 2000 Aug; 15(5):338-9. PubMed ID: 10954879
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine and risperidone.
    Love RC; Kelly DL
    Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
    [No Abstract]   [Full Text] [Related]  

  • 18. Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.
    Taylor DM; Wright T; Libretto SE;
    J Clin Psychiatry; 2003 May; 64(5):589-97. PubMed ID: 12755664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population.
    Del Paggio D; Finley PR; Cavano JM
    Clin Ther; 2002 May; 24(5):803-17. PubMed ID: 12075948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine: an atypical antipsychotic for schizophrenia.
    Lund BC; Perry PJ
    Expert Opin Pharmacother; 2000 Jan; 1(2):305-23. PubMed ID: 11249551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.